Results
Overall, 566 patients were randomized (avelumab, Demographic characteristics were similar between arms.Among patients who received ≥1 dose of study treatment in each arm (avelumab, At baseline, 1 patient (avelumab plus PLD arm) had an LVEF <LLN. Maximum change in LVEF from baseline during treatment in the (